<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> WSJ870305-0035 </DOCNO><HL> Epitope Unveils AIDS Test</HL><DD> 03/05/87</DD><SO> WALL STREET JOURNAL (J)</SO><IN> EPTDPHARMACEUTICALS, HOSPITAL SUPPLIES, MANAGEMENT (PHA) </IN><DATELINE> BEAVERTON, Ore.  </DATELINE><TEXT>   Epitope Inc. said it introduced a test that will allow doctors, hospitals or blood banks to quickly confirm diagnoses of persons carrying AIDS antibodies.    The second-tier test, administered after an initial diagnosis finds exposure to the AIDS virus, will sell for $250, the biotechnology concern said. Epitope didn't estimate potential sales of the test units, but said it values the current test market for acquired immune deficiency syndrome at about $100 million annually. </TEXT></DOC>